Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H 2 O 2 responsiveness for cancer theranostics
Theranostics · 2023
DOI: 10.7150/thno.78884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Xueluer Mu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Lab of Biobased Polymer Materials, Shandong Provincial Education Department, College of Polymer Science and Engineering, Qingdao University of Sc…. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Lab of Biobased Polymer Materials, Shandong Provincial Education Department, College of Polymer Science and Engineering, Qingdao University of Science and Technology, Qingdao, 266042, P.R. China.
- Chongqing Key Laboratory of Extraordinary Bond Engineering and Advanced Materials Technology, College of Materials Science and Engineering, Yangtze Normal University, Chongqing, 408100, P.R. China.
Zitieren
APA
Mu, X., Huang, Z., Feng, W., Zhai, M., Wang, Y., Zhou, D., & Zhou, X. (2023). Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H 2 O 2 responsiveness for cancer theranostics. Theranostics. https://doi.org/10.7150/thno.78884
Vancouver
Mu X, Huang Z, Feng W, Zhai M, Wang Y, Zhou D, et al. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H 2 O 2 responsiveness for cancer theranostics. Theranostics. 2023. doi:10.7150/thno.78884
BibTeX
@article{Mu2023,
author = {Mu, Xueluer and Huang, Zejian and Feng, Wenbi and Zhai, Manyu and Wang, Yukun and Zhou, Dan and Zhou, Xianfeng},
title = {Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H 2 O 2 responsiveness for cancer theranostics},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.78884}
}
EUVIMED